[Effect of the uterine contractility depressing agents on the electrical phenomena of the cell membrane after beta-receptors blockade].
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D004357:Drug Synergism; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D008564:Membrane Potentials / Q000187:drug effects*; D009119:Muscle Contraction / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D013565:Sympatholytics / Q000494:pharmacology*; D013566:Sympathomimetics / Q000494:pharmacology*; D014599:Uterus / Q000187:drug effects*
D013565:Sympatholytics; D013566:Sympathomimetics; D011433:Propranolol; D010208:Papaverine; D009638:Norepinephrine; D004837:Epinephrine
Wpływ srodków hamujacych czynność skurczowa macicy na zjawiska elektryczne błony komórkowej po blokadzie beta-receptorów.